Search Results - "PANKEWYCZ, O. G"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Prognostic Utility of Hypothermic Machine Perfusion in Deceased Donor Renal Transplantation by Patel, S.K, Pankewycz, O.G, Nader, N.D, Zachariah, M, Kohli, R, Laftavi, M.R

    Published in Transplantation proceedings (01-09-2012)
    “…Abstract Pulsatile pump perfusion of kidney transplants is known to decrease delayed graft function (DGF) and improve 1 year graft survival when compared to…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    Effect of Increased Pressure During Pulsatile Pump Perfusion of Deceased Donor Kidneys in Transplantation by Patel, S.K, Pankewycz, O.G, Weber-Shrikant, E, Zachariah, M, Kohli, R, Nader, N.D, Laftavi, M.R

    Published in Transplantation proceedings (01-09-2012)
    “…Abstract Introduction Pulsatile pump perfusion of potential kidneys for transplantation is known to decrease the rate of delayed graft function (DGF) and…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Graft Arteriosclerosis and Glomerulosclerosis Correlate With Flow and Resistance to Machine Perfusion in Kidney Transplantation by Patel, S.K, Pankewycz, O.G, Weber-Shrikant, E, Zachariah, M, Kohli, R, Nader, N.D, Laftavi, M.R

    Published in Transplantation proceedings (01-09-2012)
    “…Abstract Introduction Machine perfusion to preserve kidneys for transplantation has grown over the past decade with demonstrated diagnostic and therapeutic…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Transforming growth factor-β levels in human allograft chronic fibrosis correlate with rate of decline in renal function by CUHACI, B, KUMAR, M. S. A, STURGILL, B. C, PANKEWYCZ, O. G, BLOOM, R. D, PRATT, B, HAUSSMAN, G, LASKOW, D. A, ALIDOOST, M, GROTKOWSKI, C, CAHILL, K, BUTANI, L

    Published in Transplantation (27-09-1999)
    “…Long-term renal transplant function is limited primarily by a progressive scarring process loosely termed "chronic rejection, chronic allograft nephropathy, or…”
    Get full text
    Journal Article
  5. 5

    Polyreactive autoantibodies are nephritogenic in murine lupus nephritis by Pankewycz, OG, Migliorini, P, Madaio, MP

    Published in The Journal of immunology (1950) (15-11-1987)
    “…To characterize the antibodies that form glomerular immune deposits in lupus nephritis, immunoglobulin (Ig) was eluted from the perfused kidney cortices of…”
    Get full text
    Journal Article
  6. 6

    Renal TGF-β regulation in spontaneously diabetic NOD mice with correlations in mesangial cells by Pankewycz, Oleh G., Guan, Jing-Xin, Bolton, W. Kline, Gomez, Ariel, Benedict, John F.

    Published in Kidney international (01-09-1994)
    “…Renal TGF-β regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Diabetic nephropathy is characterized by excessive glomerular…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8
  9. 9

    Interleukin 2 counteracts the inhibition of cytotoxic T lymphocytes by cholera toxin in vitro and in vivo by Moscovitch-Lopatin, M, Petrillo, R J, Pankewycz, O G, Hadro, E, Bleackley, C R, Strom, T B, Wieder, K J

    Published in European journal of immunology (01-06-1991)
    “…Cholera toxin irreversibly activates a 43-kDa guanosine triphosphate (GTP)-binding protein by adenosine diphosphate ribosylation, resulting in activation of…”
    Get more information
    Journal Article
  10. 10

    Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity by Pankewycz, Oleh G., Miao, Li, Isaacs, Ross, Guan, Jing, Pruett, Tim, Haussmann, Gail, Sturgill, B.C.

    Published in Kidney international (01-11-1996)
    “…Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity. Cyclosporine A (CsA) is a…”
    Get full text
    Journal Article
  11. 11

    A protective NOD islet-infiltrating CD8+ T cell clone, I.S. 2.15, has in vitro immunosuppressive properties by Pankewycz, O G, Guan, J X, Benedict, J F

    Published in European journal of immunology (01-08-1992)
    “…Type 1, insulin-dependent diabetes mellitus (IDDM) appears to result from a T cell-dependent destruction of insulin-producing pancreatic beta cells. In…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Cytokines as mediators of autoimmune diabetes and diabetic complications by Pankewycz, O G, Guan, J X, Benedict, J F

    Published in Endocrine reviews (01-04-1995)
    “…Over the last several years, there has been a considerable and rapid expansion in our understanding of the cytokines. Insights into cytokine functions gained…”
    Get more information
    Journal Article
  14. 14

    Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum by Sabbaga, J, Pankewycz, O G, Lufft, V, Schwartz, R S, Madaio, M P

    Published in Journal of autoimmunity (01-04-1990)
    “…To distinguish the properties of anti-DNA antibodies in patients with lupus from those in normal individuals, we compared the ligand binding, idiotypic and…”
    Get more information
    Journal Article
  15. 15

    The cascading, interrelated roles of interleukin-1, interleukin-2, and interleukin-6 in murine anti-CD3-driven T cell proliferation by Pankewycz, O G, Yui, M, Kelley, V E, Strom, T B

    Published in Clinical immunology and immunopathology (01-04-1990)
    “…T cell stimulation occurs following interaction of T cell receptor (TcR) with processed antigen presented by autologous accessory cells (AC). The effects of…”
    Get more information
    Journal Article
  16. 16

    Dose-related mechanisms of immunosuppression mediated by murine anti-CD3 monoclonal antibody in pancreatic islet cell transplantation and delayed-type hypersensitivity by Mackie, J D, Pankewycz, O G, Bastos, M G, Kelley, V E, Strom, T B

    Published in Transplantation (01-06-1990)
    “…Although anti-CD3 mAb therapy is used extensively in clinical transplantation, the dose-related effects and mechanisms of action are not clearly defined. We…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Anti-interleukin-2 receptor monoclonal antibody therapy induces anti-idiotypic antibodies in mice that block both in vitro and in vivo activity by Pankewycz, O G, Hassarjian, R, Chang, C, Strom, T B, Kelley, V E

    Published in Journal of autoimmunity (01-04-1988)
    “…Monoclonal antibodies (Mab) targeting certain T cell-surface proteins including the interleukin-2 (IL2) receptor molecule exert powerful immunosuppressive…”
    Get more information
    Journal Article